Harpoon Therapeutics Inc

NASDAQ HARP

Data sourced from iex and EODHD
Download Data

Harpoon Therapeutics Inc Income Statement 2016 - 2023

This table shows the Income Statement for Harpoon Therapeutics Inc going from 2016 until 2023. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2016-12-31
Revenue
M 4 20 9 4 14 8 6 4 4 6 9 7 4 3 3 2 1 1 1 1 1 1 2 1 -
Cost of Revenue
M 0 1 1 1 - - - - - - - - - - - 13 10 10 9 9 - 6 6 5 -
Gross Profit
M 4 20 7 3 14 8 6 4 4 6 9 7 4 3 3 2 1 1 1 1 1 1 2 1 -
Operating Expenses
M 16 17 18 22 26 26 26 26 21 23 71 19 17 16 16 17 18 14 15 11 8 7 7 6 -
Selling, General, and Administrative Expenses (SG&A)
M 4 4 4 4 5 5 5 5 4 4 5 4 4 4 4 4 8 4 6 2 2 1 1 1 11
Research and Development (R&D) Expenses
M 12 12 15 19 21 21 21 21 17 18 16 15 13 12 13 13 10 10 9 9 6 6 6 5 8
Other Operating Expenses
M 0 1 -1 -1 0 0 0 0 0 0 50 0 0 0 0 0 0 0 0 0 0 0 0 0 -
Costs and Expenses
M 16 15 18 22 - - - - - - - - - - - 4 8 4 6 2 - 1 1 1 -
Operating Income
M -12 2 -11 -19 -12 -17 -20 -22 -17 -17 -62 -11 -14 -13 -13 -15 -17 -13 -14 -10 -7 -6 -5 -5 -
Interest Expense
M 2 2 0 0 0 0 0 - - - - - - - - - - - - - - - - 0 0
Non-operating Income/Expense
M 10 -2 -1 0 0 0 0 0 0 0 -50 0 0 0 0 0 0 0 0 0 0 0 0 0 -
EBT
M -2 1 -11 -18 -12 -17 -20 -22 -17 -17 -62 -11 -13 -13 -13 -14 -16 -12 -14 -10 -7 -6 -5 -5 -
Income Tax Provision
M 0 1 1 0 0 0 0 0 0 0 50 -1 0 - -1 -1 -1 -1 -1 0 0 0 0 0 -
Income after Tax
M -2 0 -12 -18 -11 -17 -20 -22 -17 -17 -112 -11 -13 - -12 -13 -15 -11 -13 -10 -7 -6 -5 -5 -
Non-Controlling Interest
M - 0 -12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - 0 0 0 -
Net Income
M - 1 1 -18 -12 -17 -20 -22 -17 -17 -62 -11 -13 -13 -13 -14 -16 -12 -14 -10 - -6 -5 -5 -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 3,947,995.00 3,797,299.00 3,696,821.00 3,368,336.00 3,306,214.00 3,303,687.00 3,287,918.00 3,270,400.00 3,263,766.00 3,250,577.00 3,157,863.00 2,525,076.00 2,508,168.00 2,496,118.00 2,482,536.00 2,460,689.00 2,445,740.00 2,429,421.00 1,475,026.00 2,390,902.00 944,807.00 944,807.00 944,807.00 9,448,070.00 -
EBITDA
M -12 5 -11 -19 -11 -17 -20 -21 -16 -16 39 -11 -13 -13 -13 -15 -17 -13 -14 -10 -7 -6 -5 -5 -
Depreciation and Amortization
M 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 -
EBIT
M -12 4 -11 -19 -12 -17 -20 -22 -17 -17 38 -12 -14 -13 -13 -15 -16 -13 -14 -10 -7 -6 -5 -5 -
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% 13.10 101.04 -6.27 1.87 2.14 0.35 -0.04 0.17 0.29 0.37 -80.78 6.06 2.25 - 4.65 7.23 3.34 9.64 3.92 2.11 1.61 1.02 1.50 -1.52 -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - 0 0 0 -
Gross Profit Margin
% 94.69 97.19 87.13 77.75 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 -
Operating Income Margin
% -272.91 12.33 -125.42 -457.62 -87.31 -209.70 -343.94 -498.06 -371.88 -287.22 -685.77 -153.46 -349.14 -474.55 -398.39 -662.71 -1,172.12 -1,189.28 -1,331.23 -928.41 -644.03 -569.61 -316.83 -705.37 -
Net Income Margin
% - 5.25 12.36 -450.45 -85.48 -208.97 -344.07 -498.31 -372.03 -287.15 -685.29 -151.59 -341.82 -459.52 -380.71 -638.68 -1,122.65 -1,111.67 -1,277.42 -915.43 - -563.88 -312.28 -697.74 -
EBITDA Ratio
% -272.91 23.34 -122.78 -457.62 -83.44 -203.10 -333.71 -485.16 -359.97 -277.82 429.55 -153.46 -335.53 -456.01 -383.14 -662.71 -1,172.12 -1,189.28 -1,303.29 -915.24 -629.07 -555.13 -307.93 -680.51 -
EBIT Ratio
% -278.21 21.51 -125.42 -474.20 -87.31 -209.70 -343.94 -498.06 -371.88 -287.22 423.46 -160.62 -349.14 -474.55 -398.39 -685.09 -1,158.29 -1,217.40 -1,331.23 -933.77 -644.03 -569.14 -316.83 -697.74 -
EBT Ratio
% -40.51 5.24 -132.10 -450.48 -85.48 -208.97 -344.07 -498.31 -372.03 -287.15 -685.29 -151.59 -341.82 -459.52 -380.71 -638.72 -1,122.65 -1,111.67 -1,277.42 -915.24 -635.84 -563.88 -312.28 -697.74 -

StockViz Staff

September 19, 2024

Any question? Send us an email